Physician profile
Parimal B Patel
NPI 1861478554
$1,166.11
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $425 · 2021: $281.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $230.14 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $215.60 | 2019-2021 | |
| Lundbeck LLC | $137.26 | 2019-2020 | |
| Abbvie INC. | $87.26 | 2021 | |
| Allergan, INC. | $84.97 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $81.53 | 2019 | |
| Neurocrine Biosciences, INC. | $81.10 | 2019-2021 | |
| Indivior INC. | $55.77 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $35.43 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $34.88 | 2020 | |
| Janssen Pharmaceuticals, INC | $22.55 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.15 | 2021 | |
| Alkermes, INC. | $20.13 | 2021 | |
| Jazz Pharmaceuticals INC. | $18.20 | 2019 | |
| Acadia Pharmaceuticals INC | $14.05 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $12.81 | 2019 | |
| Neos Therapeutics, LP | $12.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parimal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.